Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Pseudoephedrine regs

This article was originally published in The Tan Sheet

Executive Summary

Pseudoephedrine regs: "Safe harbor" for consumer packages of pseudoephedrine in final Drug Enforcement Agency reg urged by OTC drug trade association leaders in an April 4 letter to Sen. Orrin Hatch (R-Utah). Signed by Nonprescription Drug Manufacturers Association President James Cope, National Association of Chain Drug Stores President and CEO Ronald Ziegler, Food Marketing Institute President and CEO Timothy Hammonds and National Association of Retail Druggists Exec VP Charles West, the letter introduces an accompanying draft amendment to the proposed DEA reg. The amendment would "exempt from regulation the retail sale of blister-packed products that contain no more than 3.6 g of pseudoephedrine per package"...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084992

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel